These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 2408729)

  • 1. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
    Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
    Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.
    Steinberg WM; Gelfand R; Anderson KK; Glenn J; Kurtzman SH; Sindelar WF; Toskes PP
    Gastroenterology; 1986 Feb; 90(2):343-9. PubMed ID: 2416628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of CA19-9 tumor antigen in the serum of patients with carcinomas.
    Wang FM; Tsai LC; Chang ZN; Han SH; Tsao D
    Proc Natl Sci Counc Repub China B; 1985 Apr; 9(2):119-25. PubMed ID: 3863154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in patients with colorectal cancer].
    Deguchi H; Tabuchi Y; Saitoh Y
    Nihon Geka Gakkai Zasshi; 1988 May; 89(5):671-83. PubMed ID: 3166103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon-specific antigen-p (CSAp). I. Initial clinical evaluation as a marker for colorectal cancer.
    Pant KD; Shochat D; Nelson MO; Goldenberg DM
    Cancer; 1982 Sep; 50(5):919-26. PubMed ID: 6178498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
    Hayes DF; Zurawski VR; Kufe DW
    J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
    Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
    Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
    Haglund C
    Br J Cancer; 1986 Dec; 54(6):897-901. PubMed ID: 3467786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases.
    Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H
    J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma.
    Satake K; Kanazawa G; Kho I; Chung YS; Umeyama K
    J Surg Oncol; 1985 May; 29(1):15-21. PubMed ID: 3857396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
    Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E
    Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen: clinical and historical aspects.
    Martin EW; Kibbey WE; DiVecchia L; Anderson G; Catalano P; Minton JP
    Cancer; 1976 Jan; 37(1):62-81. PubMed ID: 1247968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) values in patients with pancreatic cancer or pancreatitis].
    Changchine CS; Yung CY; Tzen KY
    Changgeng Yi Xue Za Zhi; 1991 Mar; 14(1):32-8. PubMed ID: 2039968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on serum CEA levels measured by enzyme immunoassay using monoclonal CEA-antibodies].
    Takada S; Hoshi H; Ito F; Imai K; Yachi A
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1487-91. PubMed ID: 6378102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank.
    Ritts RE; Del Villano BC; Go VL; Herberman RB; Klug TL; Zurawski VR
    Int J Cancer; 1984 Mar; 33(3):339-45. PubMed ID: 6199316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
    Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O
    Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of four monoclonal antibodies to detect tumor markers.
    Kawahara M; Terasaki PI; Chia D; Johnson C; Hermes M; Tokita K
    Cancer; 1986 Nov; 58(9):2008-12. PubMed ID: 2428463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.